rasagiline krka 1 mg tabl.
krka d.d. novo mesto d.d. - rasagiline mesylate 1,44 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.44 mg - rasagiline
rasagiline teva 1 mg tabl.
teva pharma belgium sa-nv - rasagiline mesylate 1,56 mg - eq. rasagiline 1 mg - tablet - 1 mg - rasagiline mesilate 1.56 mg - rasagiline
rasagiline 1mg tablets
caduceus pharma ltd - rasagiline - tablets - 1mg - anti-parkinson-drugs, monoamine oxidase -b inhibitors - it is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
rasagiline 1mg tablets
dr reddy's laboratories (uk - rasagiline - tablet - 1mg
rasagiline 1mg tablets
a a h pharmaceuticals ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
hbs healthcare ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
accord healthcare ltd - rasagiline - tablet - 1mg
rasagiline 1mg tablets
rivopharm (uk - rasagiline - tablet - 1mg
rasagiline 1mg tablets
milpharm ltd - rasagiline - tablet - 1mg
rasalect rasagiline (as mesilate) 1 mg tablet blister pack
teva pharma australia pty ltd - rasagiline mesilate, quantity: 1.56 mg (equivalent: rasagiline, qty 1 mg) - tablet - excipient ingredients: stearic acid; purified talc; mannitol; colloidal anhydrous silica; maize starch; pregelatinised maize starch - rasalect is indicated for the symptomatic treatment of idiopathic parkinson?s disease (pd) as monotherapy and as adjunct therapy to dopamine agonists or to levodopa.